Publications
- Immunity following SARS-CoV-2 vaccination in autoimmune neurological disorders treated with rituximab or ocrelizumab2023 | First Faculty of Medicine
- To be or not to be vaccinated: The risk of MS or NMOSD relapse after COVID-19 vaccination and infection2022 | First Faculty of Medicine
- Sex bias in multiple sclerosis and neuromyelitis optica spectrum disorders: How it influences clinical course, MRI parameters and prognosis2022 | First Faculty of Medicine
- Magnetic resonance imaging findings in neuromyelitis optica spectrum disorders and disease associated with antibodies to myelin oligodendrocyte glycoprotein2022 | First Faculty of Medicine
- Pathological magnetic resonance imaging findings in myelin oligodendrocyte glycoprotein antibody-associated disease2022 | First Faculty of Medicine
- Clinical and therapeutic predictors of disease outcomes in AQP4-IgG + neuromyelitis optica spectrum disorder2020 | First Faculty of Medicine
- Deep Gray Matter Iron Content in Neuromyelitis Optica and Multiple Sclerosis2020 | First Faculty of Medicine
- Neuromyelitis optica spectrum disorders - new treatment options2020 | First Faculty of Medicine
- History of neuromyelitis optica spectrum disorders, development of the diagnostic criteria2020 | First Faculty of Medicine
- Differential diagnosis of neuromyelitis optica spectrum disorders2020 | First Faculty of Medicine
Loading network view...